Stay up-to-date with the latest Forex news

The Forex world is constantly evolving and during its weekly trading hours there is a wealth of news a trader must keep on top of if they want to make the most money possible. Indeed, because the market can be affected by a number of dynamics, it is essential they know exactly what’s happening at all times in order to avoid any unprofitable deals.

For example, let’s assume the US Dollar is trading well against the Great British Pound during the first half of the week. This would be a good time to invest some money and reap the benefits of a positive market condition. However, by Wednesday a series of negative news stories emerge from the UK and affect the country’s economic performance. These dynamics then adversely affects how well the two currencies are trading. At this point it’s important to know what’s just happened because it will influence whether or not someone should cease trading this currency pair for a while or continue.

Knowing the value of each currency based on various internal and external factors is crucial and the reason why FXBrokerSearch.com’s Forex news centre is a vital resource. Drawing on a number of resources, our information section provides the latest information and data from which users can refine their trading activity.

Beyond shifts in the currency market itself, FXBrokerSearch.com’s new section has been designed to give traders an insight into the best offers and promotions. By monitoring each of our 200+ Forex brokers we’re able to quickly tell users about the latest updates and bonuses.

By compiling all this current data into one portal we believe investors will be able to make even more money in the Forex market. Indeed, thanks to our dedicated team of analysts and experts, users can find out the latest market developments as well as the best deals in the industry. Putting all this together should help everyone gain a better understanding of the market, which in turn should give them the ability to make even more money.

468x60-instaforex-forex-broker

News

Why CBAK Energy Technology's Stock Is Trading Higher Today
Oct. 5, 2020, 7:25 p.m.

CBAK Energy Technology (NASDAQ: CBAT) shares are trading higher on Monday amid continued volatility in the lithium and EV battery space.CBAK Energy Technology is engaged in th ..

When Should You Buy Microsoft Corporation (NASDAQ:MSFT)?
Oct. 5, 2020, 7:17 p.m.

Today we're going to take a look at the well-established Microsoft Corporation (NASDAQ:MSFT). The company's stock... ..

Are Robust Financials Driving The Recent Rally In Marvell Technology Group Ltd.'s (NASDAQ:MRVL) Stock?
Oct. 5, 2020, 7:11 p.m.

Marvell Technology Group (NASDAQ:MRVL) has had a great run on the share market with its stock up by a significant 12... ..

ER Physician on President Trump's COVID-19 diagnosis: ‘I’ve never heard of another patient getting this combination of treatments'
Oct. 5, 2020, 7:09 p.m.

Dr. Darria Long, ER Physician and Clinical Assistant Professor at University of Tennessee School of Medicine, joins Yahoo Finance’s Zack Guzman to discuss Trump’s COVID-19 pro ..

An Intrinsic Calculation For Merck & Co., Inc. (NYSE:MRK) Suggests It's 27% Undervalued
Oct. 5, 2020, 6:55 p.m.

Does the October share price for Merck & Co., Inc. (NYSE:MRK) reflect what it's really worth? Today, we will estimate... ..

Why stocks are rallying while President Trump battles COVID-19
Oct. 5, 2020, 6:01 p.m.

Here's what Wall Street is saying about why the stock market is rallying as President Trump continues to battle COVID-19. ..

Gilead vs Pfizer: Which Healthcare Stock Has Stronger Prospects?
Oct. 5, 2020, 5:42 p.m.

The focus and resources of several biotech and pharma companies have shifted toward developing a vaccine or treatment for COVID-19. However, there are many companies in the he ..

Companies Like NantKwest (NASDAQ:NK) Are In A Position To Invest In Growth
Oct. 5, 2020, 5:42 p.m.

Just because a business does not make any money, does not mean that the stock will go down. Indeed, NantKwest... ..

Bristol Myers to buy heart-drug maker MyoKardia for $13.1B
Oct. 5, 2020, 5:38 p.m.

Bristol Myers is set to acquire heart-drug maker MyoKardia for $13.1 billion dollars. Yahoo Finance's Anjalee Khemlani shares the details. ..

Kratos Defense & Security Solutions (NASDAQ:KTOS) Has A Somewhat Strained Balance Sheet
Oct. 5, 2020, 5:36 p.m.

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says... ..

Social Pulse

FxBrokerSearch Newsletter

Top Brokers
#1
#2
#3
#4
#5

300x440-etoro-forex-broker

Risk Disclosure: fxBrokerSearch.com will not be held liable for any financial loss or damage caused by users acting upon any information contained within this website, not limited to and including: all numerical data, quotes, charts and buy/sell signals. Moreover, please be advised that Forex trading is one of the most volatile investment forms in the world and all trades should be placed with full consideration of the risks and costs.

fxBrokerSearch.com does not support nor encourage the execution of any investments. Trading with a margin is high risk endeavour and not suitable for everyone, therefore, each investor should carefully consider all relevant trading conditions, such as experience, risk and cost, before taking part in any type of trading, including Forex.

While every effort has been made to ensure all our data is as accurate as possible, fxBrokerSearch.com cannot be held responsible for any prices that are not in line with real-time data. Indeed, the currency exchange market is constantly changing and all CFDs (stocks, indexes, futures) and Forex prices are set by market makers.

This means advertised prices may not be accurate and could differ from the actual market conditions. For this reason it is not appropriate to rely on any data presented by fxBrokerSearch.com for the purposes of trading.

Based on these conditions, fxBrokerSearch.com will not be held responsible for any losses incurred through trades conducted in light of data presented on this site.